A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease.

Zhaojian ZhangYu WangWangxiao TanSiwei WangJinghua LiuXiao Liu Xiaoying Wang Xiu-Mei Gao

Published in: Evidence-based complementary and alternative medicine : eCAM (2019)

Danshen combined with clopidogrel may compensate for individual differences of clopidogrel resistance among individuals in the treatment of coronary heart disease. Meanwhile, the inhibitory effect of Danshen on cytochrome P450 and carboxylesterase 1 could be partly responsible for the synergistic and attenuating effects of Danshen combined with clopidogrel.

Keyphrases

acute coronary syndrome
percutaneous coronary intervention
antiplatelet therapy
coronary artery disease
combination therapy
drug delivery
atrial fibrillation
smoking cessation